ZA200202030B - Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA200202030B
ZA200202030B ZA200202030A ZA200202030A ZA200202030B ZA 200202030 B ZA200202030 B ZA 200202030B ZA 200202030 A ZA200202030 A ZA 200202030A ZA 200202030 A ZA200202030 A ZA 200202030A ZA 200202030 B ZA200202030 B ZA 200202030B
Authority
ZA
South Africa
Prior art keywords
isoindoloindolone
compounds
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA200202030A
Other languages
English (en)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Anne Rousseau
Jean Albert Boutin
Philippe Delagrange
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of ZA200202030B publication Critical patent/ZA200202030B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA200202030A 2001-03-12 2002-03-12 Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them. ZA200202030B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0103293A FR2821843B1 (fr) 2001-03-12 2001-03-12 Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200202030B true ZA200202030B (en) 2002-10-03

Family

ID=8860976

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200202030A ZA200202030B (en) 2001-03-12 2002-03-12 Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (24)

Country Link
US (1) US6465660B1 (sl)
EP (1) EP1241169B1 (sl)
JP (1) JP3842151B2 (sl)
KR (1) KR100450313B1 (sl)
CN (1) CN1159316C (sl)
AR (1) AR034583A1 (sl)
AT (1) ATE248171T1 (sl)
AU (1) AU779702B2 (sl)
BR (1) BR0200721A (sl)
CA (1) CA2376876C (sl)
DE (1) DE60200023T2 (sl)
DK (1) DK1241169T3 (sl)
EA (1) EA004035B1 (sl)
ES (1) ES2206438T3 (sl)
FR (1) FR2821843B1 (sl)
HK (1) HK1049000B (sl)
HU (1) HUP0200913A3 (sl)
MX (1) MXPA02002601A (sl)
NO (1) NO20021198L (sl)
NZ (1) NZ517742A (sl)
PL (1) PL352750A1 (sl)
PT (1) PT1241169E (sl)
SI (1) SI1241169T1 (sl)
ZA (1) ZA200202030B (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ES2276109T3 (es) * 2002-06-21 2007-06-16 Suven Life Sciences Limited Nuevos indoles arilcarbonilicos tetraciclicos que tienen afinidad por el receptor de serotonina, utiles como agentes terapeuticos, proceso para su preparacion y mezclas farmaceuticas que los contienen.
CA2490115C (en) * 2002-06-21 2009-09-01 Suven Life Sciences Limited Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
PT1567492E (pt) * 2002-11-28 2013-07-22 Suven Life Sciences Ltd N-arilsulfonil-3-aminoalcoxi-indóis
US7781476B2 (en) * 2002-12-18 2010-08-24 Suven Life Sciences Limited Tetracyclic 3-substituted indoles having serotonin receptor affinity
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
WO2024050126A2 (en) 2022-09-02 2024-03-07 Dexcom, Inc. Continuous analyte sensor devices and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377098A (en) * 1976-12-16 1978-07-08 Sumitomo Chem Co Ltd Preparation of indoloisoquinoline derivative
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US5441955A (en) * 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
FR2743365A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indolo(3,2-e)pyrazine-4-one, leur preparation et les medicaments les contenant
AU2001268677A1 (en) * 2000-06-23 2002-01-08 Cognetix, Inc. Subtype selective melatonergics

Also Published As

Publication number Publication date
NO20021198L (no) 2002-09-13
AU2324202A (en) 2002-09-19
CA2376876A1 (fr) 2002-09-12
DE60200023T2 (de) 2004-06-03
HUP0200913A2 (hu) 2002-11-28
DE60200023D1 (de) 2003-10-02
FR2821843A1 (fr) 2002-09-13
EA004035B1 (ru) 2003-12-25
PT1241169E (pt) 2003-11-28
NZ517742A (en) 2003-02-28
MXPA02002601A (es) 2004-11-12
ES2206438T3 (es) 2004-05-16
KR100450313B1 (ko) 2004-09-30
US6465660B1 (en) 2002-10-15
PL352750A1 (en) 2002-09-23
AR034583A1 (es) 2004-03-03
CN1159316C (zh) 2004-07-28
CA2376876C (fr) 2006-07-11
HU0200913D0 (sl) 2002-05-29
CN1375494A (zh) 2002-10-23
BR0200721A (pt) 2002-12-03
NO20021198D0 (no) 2002-03-11
AU779702B2 (en) 2005-02-10
JP2002265469A (ja) 2002-09-18
EP1241169B1 (fr) 2003-08-27
ATE248171T1 (de) 2003-09-15
HK1049000B (zh) 2005-01-07
EP1241169A1 (fr) 2002-09-18
SI1241169T1 (sl) 2003-12-31
JP3842151B2 (ja) 2006-11-08
DK1241169T3 (da) 2003-11-24
KR20020072782A (ko) 2002-09-18
HUP0200913A3 (en) 2004-11-29
FR2821843B1 (fr) 2003-05-09
EA200200241A1 (ru) 2002-10-31
HK1049000A1 (en) 2003-04-25

Similar Documents

Publication Publication Date Title
HK1050526A1 (en) New a-amino acid compounds, a process for their preparation and pharmaceutical compositions containing them.
HK1050357A1 (en) New-amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0402225A3 (en) Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
ZA200100864B (en) Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200108404B (en) Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200100565B (en) Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
HK1050682A1 (en) New octahydro-2h-pyridoÄ1,2-aÜpyrazine compounds, a process for their preparation and pharmaceuticalcompositions containing them.
ZA200202220B (en) Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200202030B (en) Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200205598B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200110314B (en) Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200106203B (en) Benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200205666B (en) N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200402657B (en) Isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them.
HK1053646A1 (en) BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0401038A3 (en) Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them
ZA200103064B (en) Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204757B (en) Indenoidolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200203086B (en) Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200407444B (en) Benzoindoline Compounds, a process for their preparation and pharmaceutical compositions contained them.
HK1048471A1 (en) Cycloheptene compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204865B (en) Cyclic α-amino-y-hydroxyaminde compounds, a process for their preparation and pharmaceutical compositions containing them.